I think this thread brings up a few important points ...
In a significant minority of myeloma patients with bone disease, the bone abnormality is osteopenia / osteoporosis without overt lytic lesions. This renders patients susceptible to fractures despite the absence of lesions on normal skeletal survey.
This has stimulated a question on when bone loss diseases have significance in precursor diseases.
Bone loss seems to be pretty common occurrence in precursor diseases, but Dr. Hoffman's recognition of these abnormalities as myeloma potentially indicates that some smoldering patients with osteopenia and osteoporosis may actually have active disease.
I'm just wondering when, if ever, these bone loss diseases are considered symptomatic of the myeloma, an identifiable CRAB criteria, and when they are not?
Best,
J